Expanding market access through evidence
Our Health Economics and Market Access (HEMA) and Health Economics and Outcomes Research (HEOR) teams use economic, clinical and real-world evidence to generate evidence that demonstrates the value of our therapies.
- We generate and publish peer-reviewed health economic research to strengthen the evidence available to payers and healthcare decision-makers worldwide.
- We engage with regional payers and health technology assessment (HTA) organisations to inform decisions about the adoption and funding of innovative medical technologies.
Recent articles for advancing value-based care:
Expanding access to care for underserved patients
Boston Scientific Foundation Europe (BSFE) supports non-profit organisations that are using digital innovation to solve unmet health challenges in their communities. Through initiatives that empower patients and build healthcare capacity, these programmes improve access to care and bring impactful solutions to the people who need them most.
